Search
for
Sort by
Research 30 of 1000+
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- 5α-Reduced glucocorticoids: a story of natural selection
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Hormone therapy in acne
- Skin steroidogenesis in health and disease
- Steroid Hormones
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- The Development of BL 7660 as an Anti‐Acne Agent
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Management of CAH during pregnancy
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Targets to treat androgen excess in polycystic ovary syndrome
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- Role of neurosteroids in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked neuronal injury and behavioral deficits in mice
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Ottawa, Ontario, Canada, February 13–16, 2013
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors